Filing Details
- Accession Number:
- 0001181431-11-038057
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-23 19:11:54
- Reporting Period:
- 2011-06-21
- Filing Date:
- 2011-06-23
- Accepted Time:
- 2011-06-23 19:11:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 937556 | Masimo Corp | MASI | Electromedical & Electrotherapeutic Apparatus (3845) | 330368882 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1492050 | Anthony Allan | C/O Masimo Corporation, 40 Parker Irvine CA 92618 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-06-21 | 26,476 | $30.78 | 3,524 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-06-21 | 30,000 | $23.97 | 30,000 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2011-06-21 | 30,000 | $0.00 | 30,000 | $23.97 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 120,000 | 2020-05-17 | No | 4 | M | Direct |
Footnotes
- This option was granted on May 17, 2010 ans is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
- The shares covered by this Form 4 have been transacted pursuant to a Rule 10b5-1 Sales Plan dated as of June 7, 2011, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
Billionaire Hedge Funds
